Tower Research Capital (TRC)’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.4K Buy
8,480
+4,308
+103% +$40.3K ﹤0.01% 2568
2025
Q1
$51.3K Sell
4,172
-14,018
-77% -$172K ﹤0.01% 2216
2024
Q4
$240K Buy
18,190
+11,681
+179% +$154K ﹤0.01% 1592
2024
Q3
$125K Sell
6,509
-9,146
-58% -$176K ﹤0.01% 2056
2024
Q2
$321K Buy
15,655
+14,998
+2,283% +$308K 0.01% 1709
2024
Q1
$15.6K Sell
657
-2,629
-80% -$62.6K ﹤0.01% 3229
2023
Q4
$71K Sell
3,286
-7,825
-70% -$169K ﹤0.01% 2901
2023
Q3
$161K Buy
11,111
+3,581
+48% +$52K 0.01% 1588
2023
Q2
$158K Buy
7,530
+4,374
+139% +$91.5K 0.01% 1711
2023
Q1
$67K Sell
3,156
-1,791
-36% -$38K ﹤0.01% 2246
2022
Q4
$126K Sell
4,947
-2,288
-32% -$58.3K 0.01% 1648
2022
Q3
$174K Buy
7,235
+1,490
+26% +$35.8K ﹤0.01% 2062
2022
Q2
$111K Buy
5,745
+3,434
+149% +$66.3K ﹤0.01% 2200
2022
Q1
$40K Sell
2,311
-4,782
-67% -$82.8K ﹤0.01% 2909
2021
Q4
$155K Buy
7,093
+2,192
+45% +$47.9K ﹤0.01% 1951
2021
Q3
$94K Sell
4,901
-907
-16% -$17.4K ﹤0.01% 2455
2021
Q2
$100K Buy
5,808
+4,467
+333% +$76.9K ﹤0.01% 2427
2021
Q1
$30K Buy
1,341
+246
+22% +$5.5K ﹤0.01% 3569
2020
Q4
$24K Sell
1,095
-15,949
-94% -$350K ﹤0.01% 3754
2020
Q3
$252K Buy
17,044
+13,064
+328% +$193K ﹤0.01% 2342
2020
Q2
$59K Buy
+3,980
New +$59K ﹤0.01% 2923
2019
Q4
Sell
-748
Closed -$6K 4289
2019
Q3
$6K Sell
748
-229
-23% -$1.84K ﹤0.01% 3243
2019
Q2
$9K Sell
977
-4,486
-82% -$41.3K ﹤0.01% 2629
2019
Q1
$29K Buy
5,463
+948
+21% +$5.03K ﹤0.01% 2072
2018
Q4
$20K Buy
+4,515
New +$20K ﹤0.01% 1948
2018
Q3
Sell
-1,804
Closed -$13K 4208
2018
Q2
$13K Buy
+1,804
New +$13K ﹤0.01% 2673
2017
Q4
Sell
-2,961
Closed -$35K 4049
2017
Q3
$35K Buy
+2,961
New +$35K ﹤0.01% 2302
2017
Q1
Sell
-3,547
Closed -$26K 3858
2016
Q4
$26K Buy
+3,547
New +$26K ﹤0.01% 1918
2016
Q3
Sell
-253
Closed -$2K 4381
2016
Q2
$2K Sell
253
-610
-71% -$4.82K ﹤0.01% 3959
2016
Q1
$11K Buy
+863
New +$11K ﹤0.01% 1878